Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2018 VS 2022 VS 2034
1.2.2 mRNA Translation Regulation
1.2.3 RNA Splicing Modification
1.2.4 Direct RNA Targeting
1.2.5 Indirect RNA Targeting - Epitranscriptomics
1.3 Market by Application
1.3.1 Global RNA-Targeted Small Molecules Market Growth Rate by Application: 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Laboratories
1.3.4 Phamacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global RNA-Targeted Small Molecules Market Size (2018-2034)
2.2 RNA-Targeted Small Molecules Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2034
2.3 Global RNA-Targeted Small Molecules Market Size by Region (2018-2024)
2.4 Global RNA-Targeted Small Molecules Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 RNA-Targeted Small Molecules Countries Ranking by Market Size
3 RNA-Targeted Small Molecules Competitive by Company
3.1 Global RNA-Targeted Small Molecules Revenue by Players
3.1.1 Global RNA-Targeted Small Molecules Revenue by Players (2018-2024)
3.1.2 Global RNA-Targeted Small Molecules Market Share by Players (2018-2024)
3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by RNA-Targeted Small Molecules Revenue
3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2022
3.5 Global Key Players of RNA-Targeted Small Molecules Head office and Area Served
3.6 Global Key Players of RNA-Targeted Small Molecules, Product and Application
3.7 Global Key Players of RNA-Targeted Small Molecules, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global RNA-Targeted Small Molecules Breakdown Data by Type
4.1 Global RNA-Targeted Small Molecules Historic Revenue by Type (2018-2024)
4.2 Global RNA-Targeted Small Molecules Forecasted Revenue by Type (2024-2034)
5 Global RNA-Targeted Small Molecules Breakdown Data by Application
5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2018-2024)
5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America RNA-Targeted Small Molecules Revenue by Company (2021-2024)
6.2 North America RNA-Targeted Small Molecules Revenue by Type (2018-2034)
6.3 North America RNA-Targeted Small Molecules Revenue by Application (2018-2034)
6.4 North America RNA-Targeted Small Molecules Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe RNA-Targeted Small Molecules Revenue by Company (2021-2024)
7.2 Europe RNA-Targeted Small Molecules Revenue by Type (2018-2034)
7.3 Europe RNA-Targeted Small Molecules Revenue by Application (2018-2034)
7.4 Europe RNA-Targeted Small Molecules Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific RNA-Targeted Small Molecules Revenue by Company (2021-2024)
8.2 Asia Pacific RNA-Targeted Small Molecules Revenue by Type (2018-2034)
8.3 Asia Pacific RNA-Targeted Small Molecules Revenue by Application (2018-2034)
8.4 Asia Pacific RNA-Targeted Small Molecules Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America RNA-Targeted Small Molecules Revenue by Company (2021-2024)
9.2 Latin America RNA-Targeted Small Molecules Revenue by Type (2018-2034)
9.3 Latin America RNA-Targeted Small Molecules Revenue by Application (2018-2034)
9.4 Latin America RNA-Targeted Small Molecules Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa RNA-Targeted Small Molecules Revenue by Company (2021-2024)
10.2 Middle East and Africa RNA-Targeted Small Molecules Revenue by Type (2018-2034)
10.3 Middle East and Africa RNA-Targeted Small Molecules Revenue by Application (2018-2034)
10.4 Middle East and Africa RNA-Targeted Small Molecules Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Accent Therapeutics
11.1.1 Accent Therapeutics Company Details
11.1.2 Accent Therapeutics Business Overview
11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Products and Services
11.1.4 Accent Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.1.5 Accent Therapeutics RNA-Targeted Small Molecules SWOT Analysis
11.1.6 Accent Therapeutics Recent Development
11.2 Anima Biotech Inc.
11.2.1 Anima Biotech Inc. Company Details
11.2.2 Anima Biotech Inc. Business Overview
11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Products and Services
11.2.4 Anima Biotech Inc. RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.2.5 Anima Biotech Inc. RNA-Targeted Small Molecules SWOT Analysis
11.2.6 Anima Biotech Inc. Recent Development
11.3 Arrakis Pharmaceuticals
11.3.1 Arrakis Pharmaceuticals Company Details
11.3.2 Arrakis Pharmaceuticals Business Overview
11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Products and Services
11.3.4 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.3.5 Arrakis Pharmaceuticals RNA-Targeted Small Molecules SWOT Analysis
11.3.6 Arrakis Pharmaceuticals Recent Development
11.4 Epics Therapeutics
11.4.1 Epics Therapeutics Company Details
11.4.2 Epics Therapeutics Business Overview
11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Products and Services
11.4.4 Epics Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.4.5 Epics Therapeutics RNA-Targeted Small Molecules SWOT Analysis
11.4.6 Epics Therapeutics Recent Development
11.5 Expansion Therapeutics
11.5.1 Expansion Therapeutics Company Details
11.5.2 Expansion Therapeutics Business Overview
11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Products and Services
11.5.4 Expansion Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.5.5 Expansion Therapeutics RNA-Targeted Small Molecules SWOT Analysis
11.5.6 Expansion Therapeutics Recent Development
11.6 Gotham Therapeutics
11.6.1 Gotham Therapeutics Company Details
11.6.2 Gotham Therapeutics Business Overview
11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Products and Services
11.6.4 Gotham Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.6.5 Gotham Therapeutics RNA-Targeted Small Molecules SWOT Analysis
11.6.6 Gotham Therapeutics Recent Development
11.7 H3 Biomedicine
11.7.1 H3 Biomedicine Company Details
11.7.2 H3 Biomedicine Business Overview
11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Products and Services
11.7.4 H3 Biomedicine RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.7.5 H3 Biomedicine RNA-Targeted Small Molecules SWOT Analysis
11.7.6 H3 Biomedicine Recent Development
11.8 Ribometrix
11.8.1 Ribometrix Company Details
11.8.2 Ribometrix Business Overview
11.8.3 Ribometrix RNA-Targeted Small Molecules Products and Services
11.8.4 Ribometrix RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.8.5 Ribometrix RNA-Targeted Small Molecules SWOT Analysis
11.8.6 Ribometrix Recent Development
11.9 Skyhawk Therapeutics
11.9.1 Skyhawk Therapeutics Company Details
11.9.2 Skyhawk Therapeutics Business Overview
11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Products and Services
11.9.4 Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.9.5 Skyhawk Therapeutics RNA-Targeted Small Molecules SWOT Analysis
11.9.6 Skyhawk Therapeutics Recent Development
11.10 STORM Therapeutics
11.10.1 STORM Therapeutics Company Details
11.10.2 STORM Therapeutics Business Overview
11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Products and Services
11.10.4 STORM Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.10.5 STORM Therapeutics RNA-Targeted Small Molecules SWOT Analysis
11.10.6 STORM Therapeutics Recent Development
11.11 Twentyeight-Seven Therapeutics
11.11.1 Twentyeight-Seven Therapeutics Company Details
11.11.2 Twentyeight-Seven Therapeutics Business Overview
11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Products and Services
11.11.4 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024)
11.11.5 Twentyeight-Seven Therapeutics Recent Development
12 RNA-Targeted Small Molecules Market Dynamics
12.1 RNA-Targeted Small Molecules Industry Trends
12.2 RNA-Targeted Small Molecules Market Drivers
12.3 RNA-Targeted Small Molecules Market Challenges
12.4 RNA-Targeted Small Molecules Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global RNA-Targeted Small Molecules Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of mRNA Translation Regulation
Table 3. Key Players of RNA Splicing Modification
Table 4. Key Players of Direct RNA Targeting
Table 5. Key Players of Indirect RNA Targeting - Epitranscriptomics
Table 6. Global RNA-Targeted Small Molecules Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global RNA-Targeted Small Molecules Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
Table 8. Global RNA-Targeted Small Molecules Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global RNA-Targeted Small Molecules Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 10. Global RNA-Targeted Small Molecules Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Table 11. Global RNA-Targeted Small Molecules Revenue by Players (2018-2024) & (US$ Million)
Table 12. Global RNA-Targeted Small Molecules Market Share by Players (2018-2024)
Table 13. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2022)
Table 14. Ranking of Global Top RNA-Targeted Small Molecules Companies by Revenue (US$ Million) in 2022
Table 15. Global 5 Largest Players Market Share by RNA-Targeted Small Molecules Revenue (CR5 and HHI) & (2018-2024)
Table 16. Global Key Players of RNA-Targeted Small Molecules, Headquarters and Area Served
Table 17. Global Key Players of RNA-Targeted Small Molecules, Product and Application
Table 18. Global Key Players of RNA-Targeted Small Molecules, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global RNA-Targeted Small Molecules Market Size by Type (2018-2024) & (US$ Million)
Table 21. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2024)
Table 22. Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 23. Global RNA-Targeted Small Molecules Revenue Market Share by Type (2024-2034)
Table 24. Global RNA-Targeted Small Molecules Market Size by Application (2018-2024) & (US$ Million)
Table 25. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2024)
Table 26. Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 27. Global RNA-Targeted Small Molecules Revenue Market Share by Application (2024-2034)
Table 28. North America RNA-Targeted Small Molecules Revenue by Company (2021-2024) & (US$ Million)
Table 29. North America RNA-Targeted Small Molecules Revenue by Type (2018-2024) & (US$ Million)
Table 30. North America RNA-Targeted Small Molecules Revenue by Type (2024-2034) & (US$ Million)
Table 31. North America RNA-Targeted Small Molecules Revenue by Application (2018-2024) & (US$ Million)
Table 32. North America RNA-Targeted Small Molecules Revenue by Application (2024-2034) & (US$ Million)
Table 33. North America RNA-Targeted Small Molecules Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 34. North America RNA-Targeted Small Molecules Revenue by Country (2018-2024) & (US$ Million)
Table 35. North America RNA-Targeted Small Molecules Revenue by Country (2024-2034) & (US$ Million)
Table 36. Europe RNA-Targeted Small Molecules Revenue by Company (2021-2024) & (US$ Million)
Table 37. Europe RNA-Targeted Small Molecules Revenue by Type (2018-2024) & (US$ Million)
Table 38. Europe RNA-Targeted Small Molecules Revenue by Type (2024-2034) & (US$ Million)
Table 39. Europe RNA-Targeted Small Molecules Revenue by Application (2018-2024) & (US$ Million)
Table 40. Europe RNA-Targeted Small Molecules Revenue by Application (2024-2034) & (US$ Million)
Table 41. Europe RNA-Targeted Small Molecules Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 42. Europe RNA-Targeted Small Molecules Revenue by Country (2018-2024) & (US$ Million)
Table 43. Europe RNA-Targeted Small Molecules Revenue by Country (2024-2034) & (US$ Million)
Table 44. Asia Pacific RNA-Targeted Small Molecules Revenue by Company (2021-2024) & (US$ Million)
Table 45. Asia Pacific RNA-Targeted Small Molecules Revenue by Type (2018-2024) & (US$ Million)
Table 46. Asia Pacific RNA-Targeted Small Molecules Revenue by Type (2024-2034) & (US$ Million)
Table 47. Asia Pacific RNA-Targeted Small Molecules Revenue by Application (2018-2024) & (US$ Million)
Table 48. Asia Pacific RNA-Targeted Small Molecules Revenue by Application (2024-2034) & (US$ Million)
Table 49. Asia-Pacific RNA-Targeted Small Molecules Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 50. Asia Pacific RNA-Targeted Small Molecules Revenue by Region (2018-2024) & (US$ Million)
Table 51. Asia Pacific RNA-Targeted Small Molecules Revenue by Region (2024-2034) & (US$ Million)
Table 52. Latin America RNA-Targeted Small Molecules Revenue by Company (2021-2024) & (US$ Million)
Table 53. Latin America RNA-Targeted Small Molecules Revenue by Type (2018-2024) & (US$ Million)
Table 54. Latin America RNA-Targeted Small Molecules Revenue by Type (2024-2034) & (US$ Million)
Table 55. Latin America RNA-Targeted Small Molecules Revenue by Application (2018-2024) & (US$ Million)
Table 56. Latin America RNA-Targeted Small Molecules Revenue by Application (2024-2034) & (US$ Million)
Table 57. Latin America RNA-Targeted Small Molecules Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 58. Latin America RNA-Targeted Small Molecules Revenue by Country (2018-2024) & (US$ Million)
Table 59. Latin America RNA-Targeted Small Molecules Revenue by Country (2024-2034) & (US$ Million)
Table 60. Middle East and Africa RNA-Targeted Small Molecules Revenue by Company (2021-2024) & (US$ Million)
Table 61. Middle East and Africa RNA-Targeted Small Molecules Revenue by Type (2018-2024) & (US$ Million)
Table 62. Middle East and Africa RNA-Targeted Small Molecules Revenue by Type (2024-2034) & (US$ Million)
Table 63. Middle East and Africa RNA-Targeted Small Molecules Revenue by Application (2018-2024) & (US$ Million)
Table 64. Middle East and Africa RNA-Targeted Small Molecules Revenue by Application (2024-2034) & (US$ Million)
Table 65. Middle East and Africa RNA-Targeted Small Molecules Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 66. Middle East and Africa RNA-Targeted Small Molecules Revenue by Country (2018-2024) & (US$ Million)
Table 67. Middle East and Africa RNA-Targeted Small Molecules Revenue by Country (2024-2034) & (US$ Million)
Table 68. Accent Therapeutics Company Details
Table 69. Accent Therapeutics Business Overview
Table 70. Accent Therapeutics RNA-Targeted Small Molecules Product and Services
Table 71. Accent Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 72. Accent Therapeutics RNA-Targeted Small Molecules SWOT Analysis
Table 73. Accent Therapeutics Recent Development
Table 74. Anima Biotech Inc. Company Details
Table 75. Anima Biotech Inc. Business Overview
Table 76. Anima Biotech Inc. RNA-Targeted Small Molecules Product and Services
Table 77. Anima Biotech Inc. RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 78. Anima Biotech Inc. RNA-Targeted Small Molecules SWOT Analysis
Table 79. Anima Biotech Inc. Recent Development
Table 80. Arrakis Pharmaceuticals Company Details
Table 81. Arrakis Pharmaceuticals Business Overview
Table 82. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Product and Services
Table 83. Arrakis Pharmaceuticals RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 84. Arrakis Pharmaceuticals RNA-Targeted Small Molecules SWOT Analysis
Table 85. Arrakis Pharmaceuticals Recent Development
Table 86. Epics Therapeutics Company Details
Table 87. Epics Therapeutics Business Overview
Table 88. Epics Therapeutics RNA-Targeted Small Molecules Product and Services
Table 89. Epics Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 90. Epics Therapeutics RNA-Targeted Small Molecules SWOT Analysis
Table 91. Epics Therapeutics Recent Development
Table 92. Expansion Therapeutics Company Details
Table 93. Expansion Therapeutics Business Overview
Table 94. Expansion Therapeutics RNA-Targeted Small Molecules Product and Services
Table 95. Expansion Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 96. Expansion Therapeutics RNA-Targeted Small Molecules SWOT Analysis
Table 97. Expansion Therapeutics Recent Development
Table 98. Gotham Therapeutics Company Details
Table 99. Gotham Therapeutics Business Overview
Table 100. Gotham Therapeutics RNA-Targeted Small Molecules Product and Services
Table 101. Gotham Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 102. Gotham Therapeutics RNA-Targeted Small Molecules SWOT Analysis
Table 103. Gotham Therapeutics Recent Development
Table 104. H3 Biomedicine Company Details
Table 105. H3 Biomedicine Business Overview
Table 106. H3 Biomedicine RNA-Targeted Small Molecules Product and Services
Table 107. H3 Biomedicine RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 108. H3 Biomedicine RNA-Targeted Small Molecules SWOT Analysis
Table 109. H3 Biomedicine Recent Development
Table 110. Ribometrix Company Details
Table 111. Ribometrix Business Overview
Table 112. Ribometrix RNA-Targeted Small Molecules Product and Services
Table 113. Ribometrix RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 114. Ribometrix RNA-Targeted Small Molecules SWOT Analysis
Table 115. Ribometrix Recent Development
Table 116. Skyhawk Therapeutics Company Details
Table 117. Skyhawk Therapeutics Business Overview
Table 118. Skyhawk Therapeutics RNA-Targeted Small Molecules Product and Services
Table 119. Skyhawk Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 120. Skyhawk Therapeutics RNA-Targeted Small Molecules SWOT Analysis
Table 121. Skyhawk Therapeutics Recent Development
Table 122. STORM Therapeutics Company Details
Table 123. STORM Therapeutics Business Overview
Table 124. STORM Therapeutics RNA-Targeted Small Molecules Product and Services
Table 125. STORM Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 126. STORM Therapeutics RNA-Targeted Small Molecules SWOT Analysis
Table 127. STORM Therapeutics Recent Development
Table 128. Twentyeight-Seven Therapeutics Company Details
Table 129. Twentyeight-Seven Therapeutics Business Overview
Table 130. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Product and Services
Table 131. Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Revenue in RNA-Targeted Small Molecules Business (2018-2024) & (US$ Million)
Table 132. Twentyeight-Seven Therapeutics Recent Development
Table 133. RNA-Targeted Small Molecules Market Trends
Table 134. RNA-Targeted Small Molecules Market Drivers
Table 135. RNA-Targeted Small Molecules Market Challenges
Table 136. RNA-Targeted Small Molecules Market Restraints
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. RNA-Targeted Small Molecules Product Picture
Figure 2. Global RNA-Targeted Small Molecules Market Size by Type (US$ Million): 2018 VS 2022 VS 2034
Figure 3. Global RNA-Targeted Small Molecules Market Share by Type: 2022 VS 2034
Figure 4. mRNA Translation Regulation Features
Figure 5. RNA Splicing Modification Features
Figure 6. Direct RNA Targeting Features
Figure 7. Indirect RNA Targeting - Epitranscriptomics Features
Figure 8. Global RNA-Targeted Small Molecules Market Size by Application (US$ Million): 2018 VS 2022 VS 2034
Figure 9. Global RNA-Targeted Small Molecules Market Share by Application: 2022 VS 2034
Figure 10. Hospitals
Figure 11. Laboratories
Figure 12. Phamacy
Figure 13. RNA-Targeted Small Molecules Report Years Considered
Figure 14. Global RNA-Targeted Small Molecules Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global RNA-Targeted Small Molecules Market Size 2018-2034 (US$ Million)
Figure 16. Global RNA-Targeted Small Molecules Market Size Market Share by Region: 2022 VS 2034
Figure 17. Global RNA-Targeted Small Molecules Revenue Market Share by Region in 2018 VS 2022
Figure 18. Global RNA-Targeted Small Molecules Revenue Market Share Forecast by Region (2024-2034)
Figure 19. Global Top 10 RNA-Targeted Small Molecules Countries Ranking by Market Size (US$ Million) in 2022
Figure 20. Global RNA-Targeted Small Molecules Market Size of Top 10 Countries, 2018 VS 2022 VS 2034, (US$ Million)
Figure 21. Global RNA-Targeted Small Molecules Market Share by Players in 2022
Figure 22. Global Top RNA-Targeted Small Molecules Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Targeted Small Molecules as of 2022)
Figure 23. The Top 10 and 5 Players Market Share by RNA-Targeted Small Molecules Revenue in 2022
Figure 24. North America RNA-Targeted Small Molecules Revenue Market Share by Company in 2022
Figure 25. North America RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2034)
Figure 26. North America RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2034)
Figure 27. North America RNA-Targeted Small Molecules Revenue Share by Country (2018-2034)
Figure 28. United States RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 29. Canada RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 30. Europe RNA-Targeted Small Molecules Revenue Market Share by Company in 2022
Figure 31. Europe RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2034)
Figure 32. Europe RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2034)
Figure 33. Europe RNA-Targeted Small Molecules Revenue Share by Country (2018-2034)
Figure 34. Germany RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 35. France RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 36. U.K. RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 37. Italy RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 38. Russia RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 39. Asia Pacific RNA-Targeted Small Molecules Revenue Market Share by Company in 2022
Figure 40. Asia Pacific RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2034)
Figure 41. Asia Pacific RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2034)
Figure 42. Asia Pacific RNA-Targeted Small Molecules Revenue Share by Region (2018-2034)
Figure 43. China RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 44. Japan RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 45. South Korea RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 46. India RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 47. Australia RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 48. China Taiwan RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 49. Indonesia RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 50. Thailand RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 51. Malaysia RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 52. Latin America RNA-Targeted Small Molecules Revenue Market Share by Company in 2022
Figure 53. Latin America RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2034)
Figure 54. Latin America RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2034)
Figure 55. Latin America RNA-Targeted Small Molecules Revenue Share by Country (2018-2034)
Figure 56. Mexico RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 57. Brazil RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 58. Argentina RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 59. Middle East and Africa RNA-Targeted Small Molecules Revenue Market Share by Company in 2022
Figure 60. Middle East and Africa RNA-Targeted Small Molecules Revenue Market Share by Type (2018-2034)
Figure 61. Middle East and Africa RNA-Targeted Small Molecules Revenue Market Share by Application (2018-2034)
Figure 62. Middle East and Africa RNA-Targeted Small Molecules Revenue Share by Country (2018-2034)
Figure 63. Turkey RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 64. Saudi Arabia RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 65. UAE RNA-Targeted Small Molecules Revenue (2018-2034) & (US$ Million)
Figure 66. Accent Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 67. Anima Biotech Inc. Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 68. Arrakis Pharmaceuticals Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 69. Epics Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 70. Expansion Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 71. Gotham Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 72. H3 Biomedicine Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 73. Ribometrix Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 74. Skyhawk Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 75. STORM Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 76. Twentyeight-Seven Therapeutics Revenue Growth Rate in RNA-Targeted Small Molecules Business (2018-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed